An article questioning the huge price difference in the cost of cancer drugs between US and some developing countries and offering relatively simple risk-reduction strategies. Gleevec, a drug used to treat leukemia, costs $70,000 a year in the US but only $2,500 in India. This costly gap exists thanks to US patents that prevent competitors from making and selling lower cost ... Continue Reading
Unexpected: Chemotherapy Found To Boost Cancer Growth
A team of researchers looking into why cancer cells are so resilient accidentally stumbled upon a far more important discovery. While conducting their research, the team discovered that chemotherapy actually heavily damages healthy cells and subsequently triggers them to release a protein that sustains and fuels tumor growth. Beyond that, it even makes the tumor highly ... Continue Reading